A Study of [14C]-LOXO-783 in Healthy Adult Participants
Clinical trial NCT06102512 · COMPLETED
Trial details
- NCT number
- NCT06102512
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2023-12-23
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.